Genetic Study of Amyotrophic Lateral Sclerosis in Norway
Recruiting
Observational Study
Amyotrophic Lateral Sclerosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 16 – 100
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,200 (estimated)
- Sponsor
- Sykehuset Telemark · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to explore the genetic causes relevant for ALS development in Norway.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Probable or definite ALS
* Eligible to consent
Exclusion Criteria:
\- not competent to give consent
Contacts